Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 216.90
+0.65 (0.30%)
Nov 12, 2026, 3:30 PM IST
Jagsonpal Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 451.9 | 430.82 | 553.61 | 224.63 | 267.21 | 188.55 |
Depreciation & Amortization | 90.54 | 94.44 | 81.31 | 16.63 | 11.75 | 15.26 |
Loss (Gain) From Sale of Assets | - | - | -233.59 | - | -3.59 | -0.85 |
Asset Writedown & Restructuring Costs | - | - | 1.75 | - | 28.09 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | -1.48 | -11.36 |
Stock-Based Compensation | 32.17 | 28.05 | 68.04 | 133.1 | 87.65 | - |
Provision & Write-off of Bad Debts | -0.17 | - | - | 7.67 | 2.62 | 0.42 |
Other Operating Activities | -65.78 | -61.25 | 26.64 | -85.76 | -20.66 | -8.33 |
Change in Accounts Receivable | -56.43 | -40.15 | -22.25 | 91.54 | -55.56 | -29.55 |
Change in Inventory | -22.71 | 5.28 | 0.01 | 53.1 | 86.86 | -0.18 |
Change in Accounts Payable | 11.07 | 18.47 | 21.38 | -89.82 | -19.62 | -10.75 |
Change in Other Net Operating Assets | 35.43 | -7.54 | 54.23 | 0.57 | 83.28 | -74.07 |
Operating Cash Flow | 476.02 | 468.12 | 551.13 | 351.66 | 466.55 | 69.14 |
Operating Cash Flow Growth | 18.16% | -15.06% | 56.72% | -24.63% | 574.79% | -75.50% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1.27 | -1.48 | -3.48 | -2.48 | -3.18 | -10.49 |
Sale of Property, Plant & Equipment | - | - | 357.18 | - | 12.96 | 5.81 |
Cash Acquisitions | -220.15 | -12 | -936.57 | - | - | - |
Investment in Securities | 277.93 | -444.38 | 53 | -316.67 | -620.77 | -268.57 |
Other Investing Activities | 124.03 | 101.37 | 78.4 | 73.67 | 34.28 | 15.46 |
Investing Cash Flow | 180.54 | -356.49 | -451.47 | -245.48 | -576.71 | -257.79 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt Issued | 8.72 | - | - | - | - | - |
Long-Term Debt Repaid | - | -12.21 | -9.02 | -6.33 | -0.44 | -67.88 |
Lease Payments | -14.83 | -12.21 | -9.02 | -6.33 | -0.44 | - |
Total Debt Repaid | -14.83 | -12.21 | -9.02 | -6.33 | -0.44 | -67.88 |
Net Debt Issued (Repaid) | -6.11 | -12.21 | -9.02 | -6.33 | -0.44 | -67.88 |
Issuance of Common Stock | 87.2 | 66.29 | 33.91 | 56.35 | - | - |
Repurchase of Common Stock | -401.14 | - | - | - | - | - |
Common Dividends Paid | -263.83 | -166.58 | -132.29 | -130.99 | - | -104.79 |
Other Financing Activities | -8.28 | -8.99 | -9.58 | -8.14 | -4.13 | -2.85 |
Financing Cash Flow | -592.16 | -121.49 | -116.98 | -89.11 | -4.57 | -175.52 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0.43 | - | - | - | - | - |
Net Cash Flow | 64.83 | -9.86 | -17.32 | 17.07 | -114.73 | -364.17 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 474.75 | 466.64 | 547.65 | 349.18 | 463.37 | 58.65 |
Free Cash Flow Growth | 18.48% | -14.79% | 56.84% | -24.64% | 690.06% | -78.87% |
Free Cash Flow Margin | 15.04% | 16.25% | 20.38% | 16.73% | 19.57% | 2.70% |
Free Cash Flow Per Share | 7.00 | 6.84 | 8.13 | 5.27 | 7.08 | 0.90 |
Levered Free Cash Flow | 366.1 | 397.66 | 636.37 | 197.59 | 425.62 | 49.28 |
Unlevered Free Cash Flow | 371.46 | 402.86 | 641.74 | 202.44 | 427.36 | 50.92 |
Free Cash Flow After Leases | 459.92 | 454.43 | 538.63 | 342.85 | 462.93 | 58.65 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 8.28 | 8.99 | 8.58 | 7.77 | - | 2.61 |
Cash Income Tax Paid | 139.22 | 118.98 | 81.43 | 85.13 | 72.76 | 68.73 |
Change in Working Capital | -32.64 | -23.94 | 53.37 | 55.39 | 94.96 | -114.55 |